Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_36198 | 102 | 2.13 | Mlig455_061010 | Neo: - Age: - |
TNS1 | Mlig455_061010 {REF} {Length: 1601} {Pfam: Phosphotyrosine-binding domain [PF08416.15, score=49.9]; SH2 domain [PF00017.26, score=30.3]} {Human: ENSG00000079308, TNS1, tensin 1, [Score=155, Expect=5e-42]; ENSG00000136205, TNS3, tensin 3, [Score=151, Expect=2e-40]} {Mouse: ENSMUSG00000055322, Tns1, tensin 1, [Score=155, Expect=2e-42]; ENSMUSG00000020422, Tns3, tensin 3, [Score=154, Expect=1e-41]} {Dmel: FBgn0000244, by, blistery, [Score=150, Expect=8e-41]} {Celegans: WBGene00006508, tns-1, TeNSin homolog, [Score=164, Expect=2e-48]} {Smed: dd_Smed_v6_4454_0_5, dd_Smed_v6_4454_0_5, [Score=153, Expect=5e-45]} {RNA1509_28824} {RNA1310_20281} {RNA815_21042} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -5.329 | 1.67 | 0.24444 | 0.89026 | |
RegionR2 | 1.908 | 1.67 | 0.10823 | 0.40603 | |
RegionR3 | 0.634 | 1.67 | 0.50529 | 0.99686 | |
RegionR4 | -1.221 | 1.67 | 0.99504 | 1.00000 | |
RegionR5 | -1.258 | 1.67 | 0.99454 | 1.00000 | |
RegionR6 | 0.122 | 1.67 | 0.81297 | 1.00000 | |
RegionR7 | 2.21 | 1.67 | 0.04563 | 0.41096 | |
RegionR8 | 2.934 | 1.67 | 0.01422 | 0.23155 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 3.803 | 1.67 | 0.99974 | 1.00000 | |
RegenerationR2 | 1.725 | 1.67 | 0.03748 | 0.31927 | |
RegenerationR3 | 1.742 | 1.67 | 0.05480 | 0.40237 | |
RegenerationR4 | 1.275 | 1.67 | 0.21908 | 0.66686 | |
RegenerationR5 | 1.107 | 1.67 | 0.23257 | 0.66595 | |
RegenerationR6 | 2.505 | 1.67 | 0.01443 | 0.14808 | |
RegenerationBL | 1.533 | 1.67 | 0.21272 | 0.55686 | |
RegenerationTP | 0.67 | 1.67 | 0.45239 | 0.86896 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_36198 | 102 | 2.13 | Mlig455_061010 | Neo: - Age: - |
TNS1 | 5 | 1.000 | 1.000 | - | 1.000 | 1.000 | 1.000 | Mlig455_061010 {REF} {Length: 1601} {Pfam: Phosphotyrosine-binding domain [PF08416.15, score=49.9]; SH2 domain [PF00017.26, score=30.3]} {Human: ENSG00000079308, TNS1, tensin 1, [Score=155, Expect=5e-42]; ENSG00000136205, TNS3, tensin 3, [Score=151, Expect=2e-40]} {Mouse: ENSMUSG00000055322, Tns1, tensin 1, [Score=155, Expect=2e-42]; ENSMUSG00000020422, Tns3, tensin 3, [Score=154, Expect=1e-41]} {Dmel: FBgn0000244, by, blistery, [Score=150, Expect=8e-41]} {Celegans: WBGene00006508, tns-1, TeNSin homolog, [Score=164, Expect=2e-48]} {Smed: dd_Smed_v6_4454_0_5, dd_Smed_v6_4454_0_5, [Score=153, Expect=5e-45]} {RNA1509_28824} {RNA1310_20281} {RNA815_21042} |
2. | MligTC455_36197 | 92 | 1.91 | Mlig455_053513 | Neo: - |
TNS1 | 4.901 | 0.985 | 0.991 | - | 0.931 | 0.996 | 0.998 | Mlig455_053513 {REF} {Length: 3575} {Pfam: Phosphotyrosine-binding domain [PF08416.15, score=47.7]; SH2 domain [PF00017.26, score=40.2]} {Human: ENSG00000079308, TNS1, tensin 1, [Score=177, Expect=7e-45]} {Mouse: ENSMUSG00000055322, Tns1, tensin 1, [Score=176, Expect=8e-45]; ENSMUSG00000020422, Tns3, tensin 3, [Score=169, Expect=9e-43]} {Dmel: FBgn0000244, by, blistery, [Score=166, Expect=2e-42]} {Celegans: WBGene00006508, tns-1, TeNSin homolog, [Score=181, Expect=5e-51]} {Smed: dd_Smed_v6_4494_0_2, dd_Smed_v6_4494_0_2, [Score=181, Expect=5e-48]} {RNA1509_28824, RNA1509_50496} {RNA1310_7318, RNA1509_28824, RNA1509_50496} {RNA1509_28824, RNA1509_50496, RNA815_6926} |
3. | MligTC455_36309 | 659 | 13.73 | Mlig455_000959 | Neo: - Age: - |
1.819 | 0.952 | - | - | - | - | 0.867 | Mlig455_000959 {REF} {Length: 2183} {Pfam: PH domain [PF00169.31, score=24.8]} {RNA1509_27870} {RNA1310_17063.3} {RNA815_9359.1} | |
4. | MligTC455_36274 | 15 | 0.31 | Mlig455_008085 | Neo: - Age: - |
0.992 | - | - | - | - | 0.992 | - | Mlig455_008085 {REF} {Length: 2167} {NoTransDecoderORF} {RNA1509_32205} {RNA1310_64038} {RNA815_49379} | |
5. | MligTC455_36784 | 15 | 0.3 | Mlig455_046783, Mlig455_069957 | Neo: - Age: logFC(26M/2M)=-0.515 |
0.992 | - | - | - | - | 0.992 | - | Mlig455_046783 {REF} {Length: 1605} {RNA1509_14365} {RNA1310_13117.2} {RNA815_6458.1} Mlig455_069957 {REF} {Length: 1377} {RNA1509_14365} {RNA1310_13117.4} {RNA815_6458.1} |
|
6. | MligTC455_17759 | 25 | 0.53 | Mlig455_032815 | Neo: - Age: Up-Up-Down |
0.991 | - | - | - | - | 0.991 | - | Mlig455_032815 {REF} {Length: 1891} {Pfam: Protein of unknown function (DUF2673) [PF10880.10, score=53.5]} {RNA1509_57582} {RNA1310_49538.1, RNA1509_57582} | |
7. | MligTC455_00744 | 5 | 0.11 | Mlig455_027706 | Neo: - Age: - |
0.99 | - | - | - | - | 0.990 | - | Mlig455_027706 {REF} {Length: 520} {NoTransDecoderORF} {RNA1310_47876.2} {RNA815_62057} | |
8. | MligTC455_25562 | 10 | 0.21 | Mlig455_042405 | Neo: - Age: - |
KREMEN2 | 0.981 | - | - | - | - | 0.981 | - | Mlig455_042405 {REF} {Length: 2000} {TRANSSPLICED} {Pfam: WSC domain [PF01822.21, score=47.2]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=48.1, Expect=5e-06]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=47.4, Expect=6e-06]} {RNA1509_39834} {RNA1310_29401} {RNA815_27180} |
9. | MligTC455_50866 | 73 | 1.53 | Mlig455_052918 | Neo: Int S/G2/M Age: - |
0.98 | - | - | - | - | 0.980 | - | Mlig455_052918 {REF} {Length: 3299} {RNA1509_20768} {RNA1310_18267} {RNA815_37080} | |
10. | MligTC455_25597 | 15 | 0.32 | Mlig455_042454 | Neo: - Age: - |
0.977 | - | - | - | - | 0.977 | - | Mlig455_042454 {REF} {Length: 1742} {NoTransDecoderORF} {RNA1310_68055} | |
11. | MligTC455_11966 | 21 | 0.44 | Mlig455_048087 | Neo: - Age: - |
0.972 | - | - | - | - | 0.972 | - | Mlig455_048087 {REF} {Length: 791} {RNA1509_15570} {RNA1310_9037} {RNA815_62132} | |
12. | MligTC455_29853 | 45 | 0.94 | Mlig455_026579, Mlig455_044780, Mlig455_054135 | Neo: - Age: - |
0.972 | - | - | - | - | 0.972 | - | Mlig455_026579 {REF} {Length: 430} {RNA1310_43414} Mlig455_044780 {REF} {Length: 430} {RNA1310_43414} Mlig455_054135 {REF} {Length: 4050} {Pfam: Transcriptional Coactivator p15 (PC4) [PF02229.18, score=27.4]} {RNA1509_13774} {RNA1310_6053.2} {RNA815_16908} |
|
13. | MligTC455_13329 | 95 | 1.98 | Mlig455_009198 | Neo: - |
0.971 | - | - | - | - | - | 0.971 | Mlig455_009198 {REF} {Length: 2007} {RNA1509_22077, RNA1509_32545} {RNA1310_29047.1, RNA1509_22077, RNA1509_32545} {RNA1509_22077, RNA1509_32545, RNA815_17550} | |
14. | MligTC455_38165 | 21 | 0.43 | Mlig455_027222, Mlig455_050651 | Neo: - Age: Up-Down-Down |
PKD2L1 | 0.967 | - | - | - | - | 0.967 | - | Mlig455_027222 {REF} {Length: 15740} {Pfam: REJ domain [PF02010.17, score=173.3]; Polycystin cation channel [PF08016.14, score=169.4]; F5/8 type C domain [PF00754.27, score=57.4]} {Human: ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [Score=120, Expect=2e-26]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=142, Expect=8e-33]} {Dmel: FBgn0040333, brv3, brivido-3, [Score=67.0, Expect=3e-10]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=133, Expect=3e-30]} {Smed: dd_Smed_v6_13975_0_1, dd_Smed_v6_13975_0_1, [Score=173, Expect=1e-42]} {RNA1509_58823} {RNA1310_23140.1} {RNA815_23466} Mlig455_050651 {REF} {Length: 4376} {Pfam: F5/8 type C domain [PF00754.27, score=55.0]; Lectin C-type domain [PF00059.23, score=21.4]} {RNA1509_58823} {RNA1310_38951} {RNA815_44024} |
15. | MligTC455_27211 | 14 | 0.29 | Mlig455_024750 | Neo: - Age: Down-Up-Down |
0.966 | - | - | - | - | 0.966 | - | Mlig455_024750 {REF} {Length: 887} {NoTransDecoderORF} {RNA1509_25657} {RNA1310_15620} {RNA815_11419.1} | |
16. | MligTC455_28686 | 23 | 0.47 | Mlig455_011407 | Neo: - Age: - |
0.966 | - | - | - | - | 0.966 | - | Mlig455_011407 {REF} {Length: 383} {TRANSSPLICED} {RNA1509_35740} {RNA1310_43519} {RNA815_21134} | |
17. | MligTC455_31793 | 17 | 0.36 | Mlig455_026274 | Neo: - Age: Up-Down-Up Region-enriched R4: 5.540/0.02199 |
TRIM3 | 0.966 | - | - | - | - | 0.966 | - | Mlig455_026274 {REF} {Length: 2070} {TRANSSPLICED} {Pfam: NHL repeat [PF01436.23, score=28.5]} {Human: ENSG00000110171, TRIM3, tripartite motif containing 3, [Score=62.0, Expect=2e-09]; ENSG00000109654, TRIM2, tripartite motif containing 2, [Score=62.0, Expect=2e-09]} {Mouse: ENSMUSG00000027993, Trim2, tripartite motif-containing 2, [Score=62.0, Expect=1e-09]; ENSMUSG00000036989, Trim3, tripartite motif-containing 3, [Score=62.0, Expect=1e-09]} {Dmel: FBgn0265356, tn, thin, [Score=57.4, Expect=3e-08]} {RNA1509_23300} {RNA1310_14145.1} {RNA815_3900.5} |
18. | MligTC455_39586 | 18 | 0.38 | Mlig455_048851 | Neo: - Age: - |
0.965 | - | - | - | - | 0.965 | - | Mlig455_048851 {REF} {Length: 1847} {NoTransDecoderORF} {RNA1509_25886} {RNA1310_11504.1} {RNA815_17069.1} | |
19. | MligTC455_51935 | 200 | 4.16 | Mlig455_036791 | Neo: - Age: - |
CMPK1 | 0.965 | - | - | - | - | 0.965 | - | Mlig455_036791 {REF} {Length: 1554} {Pfam: Adenylate kinase [PF00406.24, score=105.0]; AAA domain [PF13207.8, score=67.2]; AAA domain [PF13238.8, score=20.3]} {Human: ENSG00000162368, CMPK1, cytidine/uridine monophosphate kinase 1, [Score=149, Expect=8e-44]} {Mouse: ENSMUSG00000028719, Cmpk1, cytidine monophosphate (UMP-CMP) kinase 1, [Score=150, Expect=3e-44]} {Dmel: FBgn0028833, Dak1, [Score=143, Expect=3e-41]} {Celegans: WBGene00007812, C29F7.3, UMP-CMP kinase 1, [Score=137, Expect=4e-40]} {Smed: dd_Smed_v6_3353_0_1, dd_Smed_v6_3353_0_1, [Score=132, Expect=9e-38]} {RNA1509_39811} {RNA1310_32882, RNA1509_39811} {RNA1509_39811, RNA815_17820.1} |
20. | MligTC455_13116 | 127 | 2.64 | Mlig455_040518 | Neo: - Age: Up-Down-Down |
0.964 | - | - | - | - | 0.964 | - | Mlig455_040518 {REF} {Length: 2655} {TRANSSPLICED} {Pfam: Domain of unknown function (DUF3472) [PF11958.10, score=68.3]; Ricin-type beta-trefoil lectin domain-like [PF14200.8, score=27.6]; Ricin-type beta-trefoil lectin domain [PF00652.24, score=23.9]} {RNA1509_20982, RNA1509_58263} {RNA1310_18012.1, RNA1509_20982} {RNA1509_20982, RNA815_10798} | |
21. | MligTC455_01128 | 10 | 0.2 | Mlig455_011548 | Neo: - Age: - |
0.96 | - | - | - | - | 0.960 | - | Mlig455_011548 {REF} {Length: 414} {NoTransDecoderORF} {RNA1509_48793} {RNA1310_50509} {RNA815_52211} | |
22. | MligTC455_01226 | 14 | 0.3 | Mlig455_018203 | Neo: - Age: - |
0.96 | - | - | - | - | 0.960 | - | Mlig455_018203 {REF} {Length: 673} {NoTransDecoderORF} {RNA1509_35533} {RNA1310_93416} {RNA815_17588} | |
23. | MligTC455_47805 | 309 | 6.43 | Mlig455_002866, Mlig455_033201 | Neo: - |
NR2C2 | 0.959 | - | - | - | - | 0.959 | - | Mlig455_002866 {REF} {Length: 2397} {RNA1509_25172} {RNA1310_17963.1} {RNA815_11681} Mlig455_033201 {REF} {Length: 2405} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=86.4]} {Human: ENSG00000177463, NR2C2, nuclear receptor subfamily 2 group C member 2, [Score=90.5, Expect=1e-18]; ENSG00000120798, NR2C1, nuclear receptor subfamily 2 group C member 1, [Score=87.8, Expect=4e-18]; ENSG00000101076, HNF4A, hepatocyte nuclear factor 4 alpha, [Score=87.4, Expect=7e-18]; ENSG00000113580, NR3C1, nuclear receptor subfamily 3 group C member 1, [Score=87.4, Expect=2e-17]; ENSG00000175745, NR2F1, nuclear receptor subfamily 2 group F member 1, [Score=87.0, Expect=6e-18]; ENSG00000160113, NR2F6, nuclear receptor subfamily 2 group F member 6, [Score=86.7, Expect=9e-18]; ENSG00000151623, NR3C2, nuclear receptor subfamily 3 group C member 2, [Score=86.7, Expect=3e-17]} {Mouse: ENSMUSG00000005893, Nr2c2, nuclear receptor subfamily 2, group C, member 2, [Score=88.2, Expect=5e-18]; ENSMUSG00000017950, Hnf4a, hepatic nuclear factor 4, alpha, [Score=88.2, Expect=3e-18]; ENSMUSG00000069171, Nr2f1, nuclear receptor subfamily 2, group F, member 1, [Score=87.0, Expect=5e-18]; ENSMUSG00000031618, Nr3c2, nuclear receptor subfamily 3, group C, member 2, [Score=87.0, Expect=1e-17]; ENSMUSG00000005897, Nr2c1, nuclear receptor subfamily 2, group C, member 1, [Score=86.7, Expect=1e-17]; ENSMUSG00000002393, Nr2f6, nuclear receptor subfamily 2, group F, member 6, [Score=85.9, Expect=9e-18]; ENSMUSG00000030551, Nr2f2, nuclear receptor subfamily 2, group F, member 2, [Score=85.1, Expect=2e-17]; ENSMUSG00000023034, Nr4a1, nuclear receptor subfamily 4, group A, member 1, [Score=85.1, Expect=4e-17]; ENSMUSG00000024431, Nr3c1, nuclear receptor subfamily 3, group C, member 1, [Score=85.1, Expect=5e-17]; ENSMUSG00000026398, Nr5a2, nuclear receptor subfamily 5, group A, member 2, [Score=84.3, Expect=7e-17]} {Dmel: FBgn0264562, Hr4, Hormone receptor 4, [Score=96.3, Expect=1e-20]} {Celegans: WBGene00003681, nhr-91, Nuclear hormone receptor family member nhr-91, [Score=89.7, Expect=5e-19]} {Smed: dd_Smed_v6_33286_0_2, dd_Smed_v6_33286_0_2, [Score=86.7, Expect=6e-19]} {RNA1509_25172} {RNA1310_17963.1, RNA1509_25172} {RNA1509_25172, RNA815_11681} |
24. | MligTC455_01448 | 15 | 0.31 | Mlig455_063614 | Neo: - Age: - |
0.957 | - | - | - | - | 0.957 | - | Mlig455_063614 {REF} {Length: 27} {TRANSSPLICED} {NoTransDecoderORF} | |
25. | MligTC455_36850 | 102 | 2.12 | Mlig455_061130 | Neo: - Age: - |
RHBDF2 | 0.957 | - | - | - | - | 0.957 | - | Mlig455_061130 {REF} {Length: 6350} {TRANSSPLICED} {Pfam: Rhomboid family [PF01694.24, score=74.1]} {Human: ENSG00000129667, RHBDF2, rhomboid 5 homolog 2, [RH, Score=362, Expect=7e-112]; ENSG00000007384, RHBDF1, rhomboid 5 homolog 1, [RH, Score=360, Expect=5e-111]} {Mouse: ENSMUSG00000020806, Rhbdf2, rhomboid 5 homolog 2, [RH, Score=366, Expect=1e-113]} {Dmel: FBgn0041723, rho-5, rhomboid-5, [RH, Score=309, Expect=2e-89]} {Celegans: WBGene00004403, rom-4, Rhomboid-like protein, [RH, Score=313, Expect=2e-91]} {Smed: dd_Smed_v6_11534_0_2, dd_Smed_v6_11534_0_2, [RH, Score=410, Expect=3e-132]} {RNA1509_18207} {RNA1310_7108} {RNA815_9193} |
26. | MligTC455_16691 | 57 | 1.18 | Mlig455_018665 | Neo: - Age: - Region-enriched R8: 7.774/0.00104 |
0.956 | - | - | - | - | 0.956 | - | Mlig455_018665 {REF} {Length: 709} {NoTransDecoderORF} {RNA1509_25022} {RNA1310_77757} {RNA815_23623} | |
27. | MligTC455_38121 | 24 | 0.5 | Mlig455_043084 | Neo: - Age: - |
0.956 | - | - | - | - | 0.956 | - | Mlig455_043084 {REF} {Length: 3258} {NoTransDecoderORF} {RNA1509_41513} {RNA1310_17939.1, RNA1509_41513} {RNA1509_41513, RNA815_16258} | |
28. | MligTC455_38000 | 152 | 3.16 | Mlig455_032795 | Neo: - Age: Up-Down-Up Region-enriched R8: 2.697/0.04043 Regeneration-downregulated TP: -7.272 Regeneration-depleted TP: -7.272 |
0.955 | 0.955 | - | - | - | - | - | Mlig455_032795 {REF} {Length: 3332} {Pfam: Glycine rich protein [PF12810.9, score=27.1]} {RNA1509_54003, RNA1509_60023} {RNA1310_24062, RNA1509_54003, RNA1509_60023} {RNA1509_54003, RNA1509_60023, RNA815_19760} | |
29. | MligTC455_14603 | 15 | 0.31 | Mlig455_012376 | Neo: - Age: - |
0.954 | - | - | - | - | 0.954 | - | Mlig455_012376 {REF} {Length: 271} {NoTransDecoderORF} | |
30. | MligTC455_13417 | 13 | 0.26 | Mlig455_009840, Mlig455_010346 | Neo: - Age: - |
0.953 | - | - | - | - | 0.953 | - | Mlig455_009840 {REF} {Length: 1027} {NoTransDecoderORF} {RNA1310_124106} {RNA815_30229.1} Mlig455_010346 {REF} {Length: 658} {NoTransDecoderORF} {RNA1310_124106} {RNA815_30229.1} |
|
31. | MligTC455_23553 | 165 | 3.44 | Mlig455_020966 | Neo: - Age: - |
CSNK1G1 | 0.953 | - | - | - | - | 0.953 | - | Mlig455_020966 {REF} {Length: 3985} {Pfam: Protein kinase domain [PF00069.27, score=100.3]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=54.6]; Fungal protein kinase [PF17667.3, score=29.0]} {Human: ENSG00000169118, CSNK1G1, casein kinase 1 gamma 1, [RH, Score=529, Expect=0.0]; ENSG00000151292, CSNK1G3, casein kinase 1 gamma 3, [RH, Score=521, Expect=0.0]; ENSG00000133275, CSNK1G2, casein kinase 1 gamma 2, [RH, Score=514, Expect=5e-180]} {Mouse: ENSMUSG00000032384, Csnk1g1, casein kinase 1, gamma 1, [RH, Score=538, Expect=0.0]; ENSMUSG00000073563, Csnk1g3, casein kinase 1, gamma 3, [RH, Score=513, Expect=1e-179]} {Dmel: FBgn0250823, gish, gilgamesh, [RH, Score=514, Expect=9e-180]} {Celegans: WBGene00013709, csnk-1, Casein kinase I gamma, [RH, Score=513, Expect=2e-180]} {Smed: dd_Smed_v6_8508_0_2, dd_Smed_v6_8508_0_2, [RH, Score=464, Expect=3e-161]} {RNA1509_20026} {RNA1310_20582.1} {RNA815_13120.1} |
32. | MligTC455_24612 | 12 | 0.25 | Mlig455_000425, Mlig455_000489, Mlig455_000526, Mlig455_024858 | Neo: - Age: - |
SCN1A | 0.953 | - | - | - | - | 0.953 | - | Mlig455_000425 {REF} {Length: 2186} {Pfam: Ion transport protein [PF00520.33, score=296.1]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=31.9]; Polycystin cation channel [PF08016.14, score=23.2]} {Human: ENSG00000144285, SCN1A, sodium voltage-gated channel alpha subunit 1, [Score=502, Expect=4e-157]; ENSG00000136531, SCN2A, sodium voltage-gated channel alpha subunit 2, [Score=498, Expect=2e-156]; ENSG00000169432, SCN9A, sodium voltage-gated channel alpha subunit 9, [Score=490, Expect=7e-153]; ENSG00000153253, SCN3A, sodium voltage-gated channel alpha subunit 3, [Score=486, Expect=2e-151]; ENSG00000183873, SCN5A, sodium voltage-gated channel alpha subunit 5, [Score=486, Expect=9e-152]; ENSG00000196876, SCN8A, sodium voltage-gated channel alpha subunit 8, [Score=481, Expect=1e-149]; ENSG00000007314, SCN4A, sodium voltage-gated channel alpha subunit 4, [Score=481, Expect=4e-150]} {Mouse: ENSMUSG00000064329, Scn1a, sodium channel, voltage-gated, type I, alpha, [Score=500, Expect=7e-157]; ENSMUSG00000001027, Scn4a, sodium channel, voltage-gated, type IV, alpha, [Score=494, Expect=3e-155]; ENSMUSG00000075318, Scn2a, sodium channel, voltage-gated, type II, alpha, [Score=490, Expect=4e-153]; ENSMUSG00000057182, Scn3a, sodium channel, voltage-gated, type III, alpha, [Score=484, Expect=2e-151]; ENSMUSG00000075316, Scn9a, sodium channel, voltage-gated, type IX, alpha, [Score=484, Expect=4e-151]; ENSMUSG00000032511, Scn5a, sodium channel, voltage-gated, type V, alpha, [Score=483, Expect=1e-150]; ENSMUSG00000023033, Scn8a, sodium channel, voltage-gated, type VIII, alpha, [Score=481, Expect=5e-150]; ENSMUSG00000034533, Scn10a, sodium channel, voltage-gated, type X, alpha, [Score=475, Expect=6e-148]} {Dmel: FBgn0285944, para, paralytic, [Score=538, Expect=2e-170]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=189, Expect=6e-50]} {Smed: dd_Smed_v6_13973_0_1, dd_Smed_v6_13973_0_1, [Score=610, Expect=0.0]} {RNA1509_56147} {RNA1310_51142} Mlig455_000489 {REF} {Length: 2384} {Pfam: Ion transport protein [PF00520.33, score=296.0]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=31.7]; Polycystin cation channel [PF08016.14, score=23.0]} {Human: ENSG00000144285, SCN1A, sodium voltage-gated channel alpha subunit 1, [Score=504, Expect=4e-157]; ENSG00000136531, SCN2A, sodium voltage-gated channel alpha subunit 2, [Score=501, Expect=2e-156]; ENSG00000169432, SCN9A, sodium voltage-gated channel alpha subunit 9, [Score=492, Expect=9e-153]; ENSG00000183873, SCN5A, sodium voltage-gated channel alpha subunit 5, [Score=489, Expect=1e-151]; ENSG00000153253, SCN3A, sodium voltage-gated channel alpha subunit 3, [Score=488, Expect=2e-151]; ENSG00000196876, SCN8A, sodium voltage-gated channel alpha subunit 8, [Score=483, Expect=9e-150]; ENSG00000007314, SCN4A, sodium voltage-gated channel alpha subunit 4, [Score=482, Expect=8e-150]; ENSG00000185313, SCN10A, sodium voltage-gated channel alpha subunit 10, [Score=479, Expect=4e-148]} {Mouse: ENSMUSG00000064329, Scn1a, sodium channel, voltage-gated, type I, alpha, [Score=502, Expect=1e-156]; ENSMUSG00000001027, Scn4a, sodium channel, voltage-gated, type IV, alpha, [Score=496, Expect=3e-155]; ENSMUSG00000075318, Scn2a, sodium channel, voltage-gated, type II, alpha, [Score=493, Expect=2e-153]; ENSMUSG00000075316, Scn9a, sodium channel, voltage-gated, type IX, alpha, [Score=487, Expect=4e-151]; ENSMUSG00000032511, Scn5a, sodium channel, voltage-gated, type V, alpha, [Score=486, Expect=1e-150]; ENSMUSG00000057182, Scn3a, sodium channel, voltage-gated, type III, alpha, [Score=486, Expect=4e-151]; ENSMUSG00000023033, Scn8a, sodium channel, voltage-gated, type VIII, alpha, [Score=483, Expect=6e-150]; ENSMUSG00000034533, Scn10a, sodium channel, voltage-gated, type X, alpha, [Score=478, Expect=7e-148]} {Dmel: FBgn0285944, para, paralytic, [Score=541, Expect=1e-170]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=191, Expect=5e-50]} {Smed: dd_Smed_v6_14386_0_1, dd_Smed_v6_14386_0_1, [Score=627, Expect=0.0]} {RNA1509_56147} {RNA1310_51142} Mlig455_000526 {REF} {Length: 2384} {Pfam: Ion transport protein [PF00520.33, score=296.7]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=31.7]; Polycystin cation channel [PF08016.14, score=22.9]} {Human: ENSG00000144285, SCN1A, sodium voltage-gated channel alpha subunit 1, [Score=503, Expect=3e-157]; ENSG00000136531, SCN2A, sodium voltage-gated channel alpha subunit 2, [Score=501, Expect=2e-156]; ENSG00000169432, SCN9A, sodium voltage-gated channel alpha subunit 9, [Score=492, Expect=8e-153]; ENSG00000183873, SCN5A, sodium voltage-gated channel alpha subunit 5, [Score=489, Expect=8e-152]; ENSG00000153253, SCN3A, sodium voltage-gated channel alpha subunit 3, [Score=488, Expect=2e-151]; ENSG00000196876, SCN8A, sodium voltage-gated channel alpha subunit 8, [Score=484, Expect=1e-149]; ENSG00000007314, SCN4A, sodium voltage-gated channel alpha subunit 4, [Score=483, Expect=6e-150]; ENSG00000185313, SCN10A, sodium voltage-gated channel alpha subunit 10, [Score=478, Expect=5e-148]} {Mouse: ENSMUSG00000064329, Scn1a, sodium channel, voltage-gated, type I, alpha, [Score=502, Expect=1e-156]; ENSMUSG00000001027, Scn4a, sodium channel, voltage-gated, type IV, alpha, [Score=496, Expect=3e-155]; ENSMUSG00000075318, Scn2a, sodium channel, voltage-gated, type II, alpha, [Score=493, Expect=3e-153]; ENSMUSG00000075316, Scn9a, sodium channel, voltage-gated, type IX, alpha, [Score=487, Expect=4e-151]; ENSMUSG00000057182, Scn3a, sodium channel, voltage-gated, type III, alpha, [Score=486, Expect=4e-151]; ENSMUSG00000032511, Scn5a, sodium channel, voltage-gated, type V, alpha, [Score=486, Expect=2e-150]; ENSMUSG00000023033, Scn8a, sodium channel, voltage-gated, type VIII, alpha, [Score=484, Expect=5e-150]; ENSMUSG00000034533, Scn10a, sodium channel, voltage-gated, type X, alpha, [Score=478, Expect=7e-148]} {Dmel: FBgn0285944, para, paralytic, [Score=541, Expect=1e-170]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=191, Expect=6e-50]} {Smed: dd_Smed_v6_14386_0_1, dd_Smed_v6_14386_0_1, [Score=628, Expect=0.0]} {RNA1509_56147} {RNA1310_51142} Mlig455_024858 {REF} {Length: 1954} {Pfam: Ion transport protein [PF00520.33, score=318.3]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=32.1]; Polycystin cation channel [PF08016.14, score=30.0]} {Human: ENSG00000144285, SCN1A, sodium voltage-gated channel alpha subunit 1, [Score=660, Expect=0.0]; ENSG00000136531, SCN2A, sodium voltage-gated channel alpha subunit 2, [Score=654, Expect=0.0]; ENSG00000169432, SCN9A, sodium voltage-gated channel alpha subunit 9, [Score=649, Expect=0.0]; ENSG00000183873, SCN5A, sodium voltage-gated channel alpha subunit 5, [Score=640, Expect=0.0]; ENSG00000153253, SCN3A, sodium voltage-gated channel alpha subunit 3, [Score=639, Expect=0.0]; ENSG00000007314, SCN4A, sodium voltage-gated channel alpha subunit 4, [Score=635, Expect=0.0]; ENSG00000196876, SCN8A, sodium voltage-gated channel alpha subunit 8, [Score=631, Expect=0.0]; ENSG00000185313, SCN10A, sodium voltage-gated channel alpha subunit 10, [Score=627, Expect=0.0]} {Mouse: ENSMUSG00000064329, Scn1a, sodium channel, voltage-gated, type I, alpha, [Score=655, Expect=0.0]; ENSMUSG00000001027, Scn4a, sodium channel, voltage-gated, type IV, alpha, [Score=652, Expect=0.0]; ENSMUSG00000075318, Scn2a, sodium channel, voltage-gated, type II, alpha, [Score=646, Expect=0.0]; ENSMUSG00000075316, Scn9a, sodium channel, voltage-gated, type IX, alpha, [Score=645, Expect=0.0]; ENSMUSG00000057182, Scn3a, sodium channel, voltage-gated, type III, alpha, [Score=637, Expect=0.0]; ENSMUSG00000032511, Scn5a, sodium channel, voltage-gated, type V, alpha, [Score=635, Expect=0.0]; ENSMUSG00000023033, Scn8a, sodium channel, voltage-gated, type VIII, alpha, [Score=630, Expect=0.0]; ENSMUSG00000034533, Scn10a, sodium channel, voltage-gated, type X, alpha, [Score=623, Expect=0.0]} {Dmel: FBgn0285944, para, paralytic, [Score=701, Expect=0.0]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=268, Expect=3e-77]} {Smed: dd_Smed_v6_14386_0_1, dd_Smed_v6_14386_0_1, [Score=816, Expect=0.0]} {RNA1310_51142} |
33. | MligTC455_29132 | 93 | 1.93 | Mlig455_065718 | Neo: - Age: Up-Down-Up |
0.952 | - | - | - | 0.952 | - | - | Mlig455_065718 {REF} {Length: 4874} {Pfam: Fibronectin type III domain [PF00041.23, score=32.7]; 50S ribosome-binding GTPase [PF01926.25, score=24.0]; AIG1 family [PF04548.18, score=23.7]; AAA ATPase domain [PF13191.8, score=23.7]; Septin [PF00735.20, score=19.8]; RsgA GTPase [PF03193.18, score=19.8]} {RNA1509_41954} {RNA1310_1363.1, RNA1509_41954} {RNA1509_41954, RNA815_1248} | |
34. | MligTC455_54845 | 7 | 0.16 | Mlig455_011372 | Neo: - Age: - |
0.952 | - | - | - | - | 0.952 | - | Mlig455_011372 {REF} {Length: 312} {NoTransDecoderORF} | |
35. | MligTC455_01648 | 4 | 0.08 | Mlig455_065106 | Neo: - Age: - |
0.951 | - | - | - | - | 0.951 | - | Mlig455_065106 {REF} {Length: 495} {NoTransDecoderORF} {RNA1310_110067} {RNA815_57749} | |
36. | MligTC455_51603 | 39 | 0.81 | Mlig455_016769 | Neo: - Age: - |
0.951 | - | - | - | - | 0.951 | - | Mlig455_016769 {REF} {Length: 1577} {RNA1509_44500} {RNA1310_22352} {RNA815_21481} | |
37. | MligTC455_32361 | 166 | 3.47 | Mlig455_009263 | Neo: - Age: Down-Down-Up |
0.95 | - | - | - | - | 0.950 | - | Mlig455_009263 {REF} {Length: 2676} {RNA1509_34999, RNA1509_58423} {RNA1310_38117, RNA1509_58423} {RNA1509_58423, RNA815_6529.1} | |
38. | MligTC455_42902 | 28 | 0.59 | Mlig455_017220 | Neo: - Age: - |
0.95 | - | - | - | - | 0.950 | - | Mlig455_017220 {REF} {Length: 656} {NoTransDecoderORF} {RNA1509_43125} {RNA1310_24647} {RNA815_24974} |